BSX vs LSF · P/E 20, rev $16.75B vs rev $43.3M
Boston Scientific Corp (BSX) versus Laird Superfood Inc (LSF) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Laird Superfood Inc (LSF) is a packaged foods company listed on US.
Latest reported BSX revenue for 2024-12-31 was $16.75B. Net income was $1.85B. Revenue was up 17.6% from 2023-12-31 to 2024-12-31. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported LSF revenue for 2024-12-31 was $43.3M. Net income was -$1.8M. Revenue was up 26.5% from 2023-12-31 to 2024-12-31. LSF currently screens at market cap $67.1M.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. LSF currently screens at market cap $67.1M.
Not investment advice. Open the BSX and LSF stock pages for the full models.
Not investment advice.